# Jihong Zong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jihong-zong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 660 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 11 |
| i10-index | 18 |
| Last Known Institution | Bayer (United States) |
| OpenAlex ID | https://openalex.org/A5110985566 |
| Works | 55 |

## Researcher papers

- [Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.](https://scholariq.org/papers/association-of-the-cpg-island-methylator-phenotype-with-family-history-of-cancer/)
- [Assessing <i>BRCA</i> Carrier Probabilities in Extended Families](https://scholariq.org/papers/assessing-i-brca-i-carrier-probabilities-in-extended-families/)
- [Cyclin D1 Polymorphism and Increased Risk of Colorectal Cancer at Young Age](https://scholariq.org/papers/cyclin-d1-polymorphism-and-increased-risk-of-colorectal-cancer-at-young-age/)
- [TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting](https://scholariq.org/papers/trk-fusion-cancer-patient-characteristics-and-survival-analysis-in-the-real/)
- [Introducing PIONEER: a project to harness big data in prostate cancer research](https://scholariq.org/papers/introducing-pioneer-a-project-to-harness-big-data-in-prostate-cancer-research/)
- [Overall survival and second primary malignancies in men with metastatic prostate cancer](https://scholariq.org/papers/overall-survival-and-second-primary-malignancies-in-men-with-metastatic-prostate/)
- [Prostate cancer with bone metastasis in Beijing: an observational study of prevalence, hospital visits and treatment costs using data from an administrative claims database](https://scholariq.org/papers/prostate-cancer-with-bone-metastasis-in-beijing-an-observational-study-of/)
- [Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium](https://scholariq.org/papers/updating-and-integrating-core-outcome-sets-for-localised-locally-advanced/)
- [Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review](https://scholariq.org/papers/standardising-the-assessment-of-patient-reported-outcome-measures-in-localised/)
- [Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States](https://scholariq.org/papers/incidence-of-second-primary-malignancies-in-patients-with-castration-resistant/)
- [A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines](https://scholariq.org/papers/a-review-and-comparative-case-study-analysis-of-real-world-evidence-in-european/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Bayer (United States)](https://scholariq.org/institutions/bayer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.